CTNNB1 and pulmonary arterial hypertension: Previous studies have reported (Wang et al., 2023) that PASMCs in PAH patients with BMPR2 mutations exhibit CTNNB1 nuclear translocation, indicating a potential interaction between BMPR2 and the markers identified in this study.